#viral evolution — Tuesday, August 04, 2026 (1 items)
| 0 | 💬 0 |
ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.
(academic.oup.com)
|
Journal of Immunology 2026-08-04 | #covid-19 #antibody #immunotherapy #therapeutics #viral evolution |